The instruction for medical use
of the ANTI-TONSILLITIS the FORMULA
the Trade name
of the Anti-tonsillitis the Formula
the International unlicensed name
Is not present
the Dosage form
of the Tablet for resorption
One tablet contains
active agents: chlorhexidina diacetate of 2.00 mg, tetracaine hydrochloride of 0.200 mg, ascorbic acid of 50.00 mg
excipients: left menthol, saccharin, sorbitol, silicon dioxide, magnesium stearate, aromatic anise additive, aromatic mint additive, E-122 azoruby.
of the Tablet from light pink till reddish-pink color with lighter and more dark impregnations, flat with slanted edges, with an engraving of NP against the background of a tree on both parties, with a specific smell.
Drugs for treatment of diseases of a throat. Antiseptic agents.
The ATX R02AA code
Chlorhexidin properties has antibacterial activity which destroys causative agents of infectious diseases of an oral cavity and throat (streptococci, staphylococcus, pneumococci, korinebakteriya, a stick of an influenza, a klebsiyell) and antifungal activity in candidiases.
Mestnoobezbolivayushchy action local anesthetic tetracaine possesses.
Vitamin C increases body resistance to infectious diseases.
– prevention and topical treatment of inflammatory diseases
of an oral cavity and nasopharynx (stomatitis, an ulitis, a tonsillitis, pharyngitis,
– elimination of consequences of Qatar of upper airways,
removal of hypostasis of phonatory bands and tonsils
– a state after tonsilectomy, extraction of tooth
to Hold the Route of administration in a mouth before full resorption.
Adults: 6 tablets a day at an interval of the 2nd hour.
Course of treatment no more than 10 days.
– allergic reactions
of the Contraindication
– hypersensitivity to drug components
– pregnancy, the lactation period
– children’s, teenage age up to 18 years
Tetracaine reduces antibacterial activity of sulfanamide drugs. Vasoconstrictors extend effect and reduce toxicity of tetracaine. Ascorbic acid increases concentration in blood of benzylpenicillin and tetracyclines, increases risk of development of a crystalluria at treatment by salicylates and streptocides of short action, reduces concentration in blood of oral contraceptives.
it is not necessary to exceed the recommended drug doses.
Influence of drug on ability to run motor transport or potentially dangerous mechanisms
does not influence
Symptoms: headache, cyanosis, muscular tremor, nausea, vomiting.
Treatment: gastric lavage, symptomatic therapy.
A form of release and packing
of the Tablet for resorption.
On 10 tablets place in blister strip packaging from a film of polyvinylchloride and aluminum foil.
On 2 planimetric packs together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions at a temperature not above 25 °C.
To store out of children’s reach!
not to apply a period of storage after an expiration date.
of Natures Europe Product B. B., Tveyberg 17, 5246 XL Rozmalen
the Packer B.V. Herkel, Nobeltseg 6, 3899 BN Zeevolda, the Netherlands
the Owner of the registration certificate
of OOO Valeant, Russia
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products Representative office of OOO Valeant to RKKazahstan, 050059, Almaty, Al-Farabi Avenue, 17, Business center Nurly-Tau Block 4B, office 1104 Phone number + 7 727 3 111 516, fax +7 727 3 111 517 E-mail: Office.KZ@valeant.com